Israeli Study Finds 94% Drop in Symptomatic COVID-19 Cases with Pfizer Vaccine

In addition to this finding, the same group was also 92% less likely to develop severe illness from the virus compared to a group of the same size, with matching medical histories, who had not received the vaccine.